Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1982 1
1983 2
1984 5
1985 5
1986 3
1987 1
1988 1
1989 2
1990 2
1991 2
1992 1
1993 1
1994 3
1995 3
1996 8
1997 1
2001 1
2002 2
2003 3
2004 1
2005 6
2006 2
2007 3
2008 22
2009 18
2010 25
2011 21
2012 16
2013 20
2014 21
2015 20
2016 8
2017 11
2018 9
2019 6
2020 3
2021 9
2022 11
2023 5
2024 7
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Results by year

Filters applied: . Clear all
Page 1
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Takahashi N, Kim I, Etienne G, Andorsky D, Issa GC, Larson RA, Bombaci F, Kapoor S, McCulloch T, Malek K, Yau L, Ifrah S, Hoch M, Cortes JE, Hughes TP; ASC4FIRST Investigators. Hochhaus A, et al. N Engl J Med. 2024 Sep 12;391(10):885-898. doi: 10.1056/NEJMoa2400858. Epub 2024 May 31. N Engl J Med. 2024. PMID: 38820078 Clinical Trial.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.
Ikoma Y, Nakamura N, Kaneda Y, Takamori H, Seki T, Hiramoto N, Kitagawa J, Kanda J, Fujita K, Morishita T, Ochi Y, Chiba S, Sasaki N, Ichii M, Imada K, Watanabe M, Hishizawa M, Miyahara Y, Maesako Y, Tanaka Y, Oka S, Tsuji M, Yoshihara S, Mitani K, Ueda Y, Kitano T, Watanabe M, Sezaki N, Kondo T, Kasahara S, Takaori-Kondo A, Kanemura N, Ogawa S, Nannya Y. Ikoma Y, et al. Among authors: ichii m. Leukemia. 2025 Jun;39(6):1362-1367. doi: 10.1038/s41375-025-02625-3. Epub 2025 Apr 21. Leukemia. 2025. PMID: 40259101 Free PMC article.
CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant.
Ikeda S, Hasegawa K, Kogue Y, Arimori T, Kawamoto R, Wibowo T, Yaga M, Inada Y, Uehara H, Matsubara M, Tachikawa M, Suga M, Kida S, Shibata K, Tsutsumi K, Fukushima K, Fujita J, Ueda T, Kusakabe S, Hino A, Ichii M, Hirose A, Nakamae H, Hino M, Nakao T, Inoue M, Yoshihara K, Yoshihara S, Ueda S, Tachi T, Kuroda H, Murakami K, Kijima N, Kishima H, Igashira E, Murakami M, Takiuchi T, Kimura T, Hiroshima T, Kimura T, Shintani Y, Imai C, Yusa K, Mori R, Ogino T, Eguchi H, Takeda K, Oji Y, Kumanogoh A, Takagi J, Hosen N. Ikeda S, et al. Among authors: ichii m. Nat Cancer. 2025 Apr;6(4):595-611. doi: 10.1038/s43018-025-00934-1. Epub 2025 Mar 24. Nat Cancer. 2025. PMID: 40128569
CAR-NK cells derived from cord blood originate mainly from CD56-CD7+CD34-HLA-DR-Lin- NK progenitor cells.
Wibowo T, Kogue Y, Ikeda S, Yaga M, Tachikawa M, Suga M, Kida S, Shibata K, Tsutsumi K, Murakami H, Ueda Y, Kato H, Fukushima K, Fujita J, Ueda T, Kusakabe S, Hino A, Ichii M, Imai C, Okuzaki D, Kumanogoh A, Hosen N. Wibowo T, et al. Among authors: ichii m. Mol Ther Methods Clin Dev. 2024 Nov 12;32(4):101374. doi: 10.1016/j.omtm.2024.101374. eCollection 2024 Dec 12. Mol Ther Methods Clin Dev. 2024. PMID: 39659759 Free PMC article.
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST.
Takahashi N, Kikushige Y, Nakamae H, Goto T, Tomita A, Ichii M, Ito S, Teshima T, Kirito K, Ikezoe T, Hatano K, Tanaka H, Hiramoto N, Osako R, Aoki M, Malek K, Ueda Y. Takahashi N, et al. Among authors: ichii m. Int J Hematol. 2025 Nov;122(5):647-659. doi: 10.1007/s12185-025-04014-z. Epub 2025 May 26. Int J Hematol. 2025. PMID: 40418277 Clinical Trial.
Trends in teicoplanin loading dose implementation from 2010 to 2019 and evaluation of safety and efficacy factors: a retrospective cohort study based on a Japanese administrative claims database.
Goto R, Muraki Y, Inose R, Ichii M, Sawada K, Mizuno K, Koizumi R, Tsuzuki S, Ishikane M, Ohmagari N. Goto R, et al. Among authors: ichii m. J Pharm Health Care Sci. 2023 Nov 1;9(1):35. doi: 10.1186/s40780-023-00304-y. J Pharm Health Care Sci. 2023. PMID: 37908001 Free PMC article.
CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy.
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T, Shirai Y, Tansri W, Uehara H, Tachikawa M, Okairi Y, Sone M, Mori H, Kogue Y, Akamine H, Okuzaki D, Kawagishi K, Kawanaka S, Yamato H, Takeuchi Y, Okura E, Kanzaki R, Okami J, Nakamichi I, Nakane S, Kobayashi A, Iwazawa T, Tokunaga T, Yokouchi H, Yano Y, Uchida J, Mori M, Komuta K, Tachi T, Kuroda H, Kijima N, Kishima H, Ichii M, Futami S, Naito Y, Shiroyama T, Miyake K, Koyama S, Hirata H, Takeda Y, Funaki S, Shintani Y, Kumanogoh A, Hosen N. Yaga M, et al. Among authors: ichii m. Sci Rep. 2024 Aug 2;14(1):17917. doi: 10.1038/s41598-024-68779-9. Sci Rep. 2024. PMID: 39095551 Free PMC article.
264 results